1105 related articles for article (PubMed ID: 19782780)
61. The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.
Takaoka S; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Horm Metab Res; 2010 Aug; 42(9):627-31. PubMed ID: 20560105
[TBL] [Abstract][Full Text] [Related]
62. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
Kim BS; Kang HJ; Park JY; Lee J
Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
[TBL] [Abstract][Full Text] [Related]
63. Angiopoietins contribute to lung development by regulating pulmonary vascular network formation.
Hato T; Kimura Y; Morisada T; Koh GY; Miyata K; Tabata M; Kadomatsu T; Endo M; Urano T; Arai F; Araki K; Suda T; Kobayashi K; Oike Y
Biochem Biophys Res Commun; 2009 Apr; 381(2):218-23. PubMed ID: 19217887
[TBL] [Abstract][Full Text] [Related]
64. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway.
Chen PY; Sun JS; Tsuang YH; Chen MH; Weng PW; Lin FH
Nutr Res; 2010 Mar; 30(3):191-9. PubMed ID: 20417880
[TBL] [Abstract][Full Text] [Related]
65. Cartilage oligomeric matrix protein enhances osteogenesis by directly binding and activating bone morphogenetic protein-2.
Ishida K; Acharya C; Christiansen BA; Yik JH; DiCesare PE; Haudenschild DR
Bone; 2013 Jul; 55(1):23-35. PubMed ID: 23528838
[TBL] [Abstract][Full Text] [Related]
66. COMP-Ang1 inhibits apoptosis as well as improves the attenuated osteogenic differentiation of mesenchymal stem cells induced by advanced glycation end products.
Kim S; Kwon J
Biochim Biophys Acta; 2013 Oct; 1830(10):4928-34. PubMed ID: 23850469
[TBL] [Abstract][Full Text] [Related]
67. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.
Yuan HT; Venkatesha S; Chan B; Deutsch U; Mammoto T; Sukhatme VP; Woolf AS; Karumanchi SA
FASEB J; 2007 Oct; 21(12):3171-83. PubMed ID: 17504972
[TBL] [Abstract][Full Text] [Related]
68. High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1.
Singh H; Brindle NP; Zammit VA
Microvasc Res; 2010 Mar; 79(2):121-7. PubMed ID: 20079751
[TBL] [Abstract][Full Text] [Related]
69. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
70. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury.
Jung YJ; Kim DH; Lee AS; Lee S; Kang KP; Lee SY; Jang KY; Sung MJ; Park SK; Kim W
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F952-60. PubMed ID: 19656917
[TBL] [Abstract][Full Text] [Related]
71. Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF.
Metheny-Barlow LJ; Tian S; Hayes AJ; Li LY
Microvasc Res; 2004 Nov; 68(3):221-30. PubMed ID: 15501241
[TBL] [Abstract][Full Text] [Related]
72. Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation.
Park KS; Shim EY; Choi BK; Moon C; Kim SH; Kim YS; Kwon CH; Joh JW; Koh GY; Kim SJ
Transplant Proc; 2010 Sep; 42(7):2653-7. PubMed ID: 20832563
[TBL] [Abstract][Full Text] [Related]
73. Protective role of COMP-Ang1 in ischemic rat brain.
Shin HY; Lee YJ; Kim HJ; Park CK; Kim JH; Wang KC; Kim DG; Koh GY; Paek SH
J Neurosci Res; 2010 Apr; 88(5):1052-63. PubMed ID: 19885826
[TBL] [Abstract][Full Text] [Related]
74. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.
Kim HZ; Jung K; Kim HM; Cheng Y; Koh GY
Biochim Biophys Acta; 2009 May; 1793(5):772-80. PubMed ID: 19339208
[TBL] [Abstract][Full Text] [Related]
75. Cyclic AMP Response Element-binding Protein H (CREBH) Mediates the Inhibitory Actions of Tumor Necrosis Factor α in Osteoblast Differentiation by Stimulating Smad1 Degradation.
Jang WG; Jeong BC; Kim EJ; Choi H; Oh SH; Kim DK; Koo SH; Choi HS; Koh JT
J Biol Chem; 2015 May; 290(21):13556-66. PubMed ID: 25873397
[TBL] [Abstract][Full Text] [Related]
76. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
[TBL] [Abstract][Full Text] [Related]
77. Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation.
Laflamme C; Curt S; Rouabhia M
Arch Oral Biol; 2010 Sep; 55(9):689-701. PubMed ID: 20627196
[TBL] [Abstract][Full Text] [Related]
78. Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor.
Liu H; Liu Y; Viggeswarapu M; Zheng Z; Titus L; Boden SD
J Bone Miner Res; 2011 May; 26(5):1122-32. PubMed ID: 21542012
[TBL] [Abstract][Full Text] [Related]
79. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
[TBL] [Abstract][Full Text] [Related]
80. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
